DDRE-08. POTENTIAL THERAPEUTIC EFFECTS OF ETOMOXIR IN COMBINATION WITH TEMOZOLOMIDE AGAINST HUMAN GLIOBLASTOMA TUMORSPHERES

PURPOSE: Glioblastoma (GBM) is the most common and lethal brain tumor with the median survival between 10 and 14 months. Since current treatments including surgical resection, radiation and chemotherapy fail to cure GBM, a new strategy to maximize the efficacy is needed. Here, etomoxir, an inhibitor...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Neuro Oncol
Päätekijät: Hyun Kim, Eui, Shim, Jin-Kyoung, Park, Jungseong, Seon, Jieun, Kim, Hyun Sil, Moon, Ju Hyung, Chang, Jong Hee, Yook, Jong In, Kang, Seok-Gu
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2020
Aiheet:
Drug Discovery, Drug Resistance
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650461/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.253
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia